Nancy Jones
Family Medicine · Gravette, ARNPI 1346208527
Payments from drug & device makers
Across 88 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$292
- Astellas Pharma US Inc$280
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
- Abbott$107
- Pfizer$102
- Novo Nordisk$65
- plus $783 from 25 others
What the payments were for
- Food & beverage$1,43882%
- Education$31518%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $292 |
| Astellas Pharma US Inc | 3 | $280 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $125 |
| Abbott | 6 | $107 |
| Pfizer | 6 | $102 |
| Novo Nordisk | 4 | $65 |
| Amgen(2 entities) | 4 | $63 |
| Lilly USA, LLC | 4 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| GSK | 3 | $48 |
| Exact Sciences | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Dexcom, Inc. | 2 | $38 |
| AstraZeneca | 3 | $36 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| Vertex | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 1 | $26 |
| BETA Bionics, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Bayer | 1 | $14 |
| Gilead | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,753 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $54,242 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 64 | $53,131 |
| EliquisApixaban | 77 | $51,154 |
| XareltoRivaroxaban | 27 | $26,800 |
| MounjaroTirzepatide | 24 | $25,535 |
| EntrestoSacubitril/Valsartan | 48 | $25,514 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 679 | $23,487 |
| RybelsusSemaglutide | 15 | $18,703 |
| LinzessLinaclotide | 20 | $15,971 |
| JanuviaSitagliptin Phosphate | 21 | $15,142 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $15,036 |
| Emgality PenGalcanezumab-Gnlm | 19 | $13,502 |
| Buprenorphine | 48 | $12,397 |
| MyrbetriqMirabegron | 15 | $10,397 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 318 | $9,558 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $65 | $72,94572 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $48 | $60,38182 claims |
| PfizerEliquis | $102 | $51,15477 claims |
| Johnson & JohnsonXarelto | $18 | $26,80027 claims |
| Lilly USA, LLCMounjaro | $56 | $25,53524 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $36 | $20,51837 claims |
| AbbVieLinzess | $292 | $15,97120 claims |
| Hikma Pharmaceuticals USABuprenorphine | $35 | $12,39748 claims |
| Astellas Pharma US IncMyrbetriq | $280 | $10,39715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Gravette
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.